Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New antidiabetic agent from Japan Tobacco

June 10, 1997

Agent for gastroparesis in diabetic patients

June 10, 1997

Studies reported on absorption of the insulin analogue HOE-901

June 10, 1997

BRL-49653: Profile of a potential new antidiabetic agent

June 10, 1997

BTS-67582 preclinical and clinical trials results

June 10, 1997

Promising clinical results reported for Flt3 ligand as stem cell mobilizer

June 9, 1997

TKT reaches milestone in second Gene Activation collaboration with HMR

June 9, 1997

Phase III results with Lilly's raloxifene reported

June 6, 1997

r-metHuSCF + filgrastrim for PBPC mobilization and transplantation: a phase I/II trial

June 6, 1997

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...